288 related articles for article (PubMed ID: 15469850)
1. Advances in the clinical laboratory detection of gestational trophoblastic disease.
Seki K; Matsui H; Sekiya S
Clin Chim Acta; 2004 Nov; 349(1-2):1-13. PubMed ID: 15469850
[TBL] [Abstract][Full Text] [Related]
2. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
3. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
4. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
Khanlian SA; Cole LA
J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
[TBL] [Abstract][Full Text] [Related]
5. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
[TBL] [Abstract][Full Text] [Related]
6. Inappropriate management of women with persistent low hCG results.
Cole LA; Khanlian SA
J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
[TBL] [Abstract][Full Text] [Related]
7. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.
Bakhtiyari M; Mirzamoradi M; Kimyaiee P; Aghaie A; Mansournia MA; Ashrafi-Vand S; Sarfjoo FS
Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850
[TBL] [Abstract][Full Text] [Related]
8. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
9. [Utility of hCG dosage in the management of gestational trophoblastic diseases].
Zohoun AG; Hounmenou K; Mechtani Sel I; Razine R; Dami A; Filali A; Rahali DM; Tellal S
Ann Biol Clin (Paris); 2013; 71(6):639-43. PubMed ID: 24342784
[TBL] [Abstract][Full Text] [Related]
10. Quantitative urine hCG and urine pregnancy test in gestational trophoblastic disease patients with low hCG titer.
Lertkhachonsuk R
J Med Assoc Thai; 2015 Jan; 98 Suppl 1():S36-41. PubMed ID: 25764611
[TBL] [Abstract][Full Text] [Related]
11. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
[TBL] [Abstract][Full Text] [Related]
12. What we know about low-level hCG: definition, classification and management.
Kohorn EI
J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
[TBL] [Abstract][Full Text] [Related]
13. A 10-Year Clinical Experience of Gestational Trophoblastic Disease at Rajavithi Hospital, 2001-2010.
Yanaranop M; Potikul C; Tuipae S
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S17-27. PubMed ID: 27266212
[TBL] [Abstract][Full Text] [Related]
14. Hormonal measurements in patients with theca lutein cysts and gestational trophoblastic disease.
Osathanondh R; Berkowitz RS; de Cholnoky C; Smith BS; Goldstein DP; Tyson JE
J Reprod Med; 1986 Mar; 31(3):179-83. PubMed ID: 3009803
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
Zhou Y; Feng FZ; Xiang Y; Wan XR
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):804-7. PubMed ID: 21211275
[TBL] [Abstract][Full Text] [Related]
16. Recurrent gestational trophoblastic disease in a case of suspected quiescent gestational trophoblastic disease: a case report.
Sasaki S; Sasaki Y; Iino K
J Reprod Med; 2010; 55(7-8):317-20. PubMed ID: 20795345
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 2 Human Chorionic Gonadotropin Immunoassays Commercially Available for Monitoring Patients With Gestational Trophoblastic Disease.
de Souza JMQ; Braga A; Sanches Dos Santos R; Ramos MM; Cortés-Charry R; Maestá I
Int J Gynecol Cancer; 2017 Sep; 27(7):1494-1500. PubMed ID: 28692637
[TBL] [Abstract][Full Text] [Related]
18. [Persistent low levels of human chorionic gonadotropin in the serum: investigation and management].
Faranesh R; Ben-David Y
Harefuah; 2009 Feb; 148(2):101-3, 139. PubMed ID: 19627038
[TBL] [Abstract][Full Text] [Related]
19. Update on the diagnosis and management of gestational trophoblastic disease.
Ngan HYS; Seckl MJ; Berkowitz RS; Xiang Y; Golfier F; Sekharan PK; Lurain JR; Massuger L
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():79-85. PubMed ID: 30306586
[TBL] [Abstract][Full Text] [Related]
20. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
Lybol C; Sweep FC; Ottevanger PB; Massuger LF; Thomas CM
Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
